{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T12:54:54Z","timestamp":1773752094366,"version":"3.50.1"},"reference-count":41,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0166649","type":"journal-article","created":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T19:23:34Z","timestamp":1480620214000},"page":"e0166649","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":14,"title":["Assessment of the World Health Organization\u2019s HIV Drug Resistance Early Warning Indicators in Main and Decentralized Outreach Antiretroviral Therapy Sites in Namibia"],"prefix":"10.1371","volume":"11","author":[{"given":"Nicholus","family":"Mutenda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Bukowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Marie","family":"Nitschke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tuli","family":"Nakanyala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ndapewa","family":"Hamunime","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadesse","family":"Mekonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francina","family":"Tjituka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Greatjoy","family":"Mazibuko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samson","family":"Mwinga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Mabirizi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evans","family":"Sagwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosalia","family":"Indongo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalie","family":"Dean","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael R.","family":"Jordan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven Y.","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2016,12,1]]},"reference":[{"key":"ref1","unstructured":"UNAIDS. Fact Sheet 2016. Accessed October 7, 2016. http:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/UNAIDS_FactSheet_en.pdf<\/ext-link>"},{"key":"ref2","article-title":"Ambitious Treatment Targets: Writing the Final Chapter of the AIDS Epidemic","year":"2014"},{"key":"ref3","unstructured":"WHO. Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV. September 2015. http:\/\/apps.who.int\/iris\/bitstream\/10665\/186275\/1\/9789241509565_eng.pdf?ua=1<\/ext-link>"},{"issue":"1","key":"ref4","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/01.aids.0000433239.01611.52","article-title":"Averted HIV infections due to expanded antiretroviral treatment eligibility offsets risk of transmitted drug resistance: a modeling study","volume":"28","author":"BE Nichols","year":"2014","journal-title":"AIDS"},{"issue":"Suppl 1","key":"ref5","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1097\/QAD.0000000000000082","article-title":"Predicted levels of HIV drug resistance: potential impact of expanding diagnosis, retention, and eligibility criteria for antiretroviral therapy initiation","volume":"28","author":"V Cambiano","year":"2014","journal-title":"AIDS"},{"key":"ref6","unstructured":"WHO. HIV drug resistance surveillance guidance: 2015 update. December 2015. http:\/\/www.who.int\/hiv\/pub\/drugresistance\/hiv-drug-resistance-2015-update\/en\/<\/ext-link>"},{"key":"ref7","unstructured":"World Health Organization. Using early warning indicators to prevent HIV drug resistance. Report of the Early Advisory Indicator Panel meeting (11\u201312 August 2011). http:\/\/www.who.int\/hiv\/pub\/meetingreports\/ewi_meeting_report\/en\/<\/ext-link>"},{"key":"ref8","unstructured":"WHO. Global Report On Early Warning Indicators of HIV Drug Resistance. July 2016. Accessed October 7, 2016. http:\/\/www.who.int\/hiv\/pub\/drugresistance\/ewi-hivdr-2016\/en\/<\/ext-link>"},{"key":"ref9","unstructured":"UNAIDS. HIV and AIDS estimates (2015). Accessed on October 7, 2016. http:\/\/www.unaids.org\/en\/regionscountries\/countries\/namibia<\/ext-link>"},{"key":"ref10","unstructured":"Central Intelligence Agency. The World Factbook. Accessed on October 7, 2016. https:\/\/www.cia.gov\/library\/publications\/the-world-factbook\/geos\/wa.html<\/ext-link>"},{"key":"ref11","unstructured":"Republic of Namibia Ministry of Health and Social Services Directorate of Special Programmes Surveillance Report of the 2014 National HIV Sentinel Survey. November 2014. http:\/\/www.mhss.gov.na\/files\/downloads\/12f_2014%20National%20HIV%20Sentinel%20Survey.pdf<\/ext-link>"},{"key":"ref12","unstructured":"WHO. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. 30 June, 2013. Accessed on October 7, 2016 http:\/\/www.who.int\/hiv\/pub\/guidelines\/arv2013\/download\/en\/<\/ext-link>"},{"key":"ref13","unstructured":"Republic of Namibia Ministry of Health and Social Services, Directorate of Special Programmes National Guidelines for Antiretroviral Therapy, Revised Fourth Edition. January 2014. http:\/\/www.emtct-iatt.org\/wp-content\/uploads\/2014\/06\/Namibia-National-ART-guidelines-2014.pdf<\/ext-link>"},{"key":"ref14","unstructured":"USAID. Namibia Program Profile, Strengthening Health Outcomes through the Private Sector Project. 2015. http:\/\/abtassociates.com\/AbtAssociates\/files\/ca\/caf5f496-62d5-4fda-a8dd-39d0464d0231.pdf<\/ext-link>"},{"issue":"4","key":"ref15","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/QAI.0b013e3181f5376d","article-title":"Population-based Monitoring of HIV Drug Resistance in Namibia with Early Warning Indicators","volume":"55","author":"SY Hong","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"6","key":"ref16","doi-asserted-by":"crossref","first-page":"e65653","DOI":"10.1371\/journal.pone.0065653","article-title":"HIV drug resistance early warning indicators in Namibia for public health action","volume":"8","author":"A Jonas","year":"2013","journal-title":"PLoS One"},{"issue":"7","key":"ref17","doi-asserted-by":"crossref","first-page":"e100539","DOI":"10.1371\/journal.pone.0100539","article-title":"HIV drug resistance early warning indicators in Namibia with updated World Health Organization guidance","volume":"9","author":"A Jonas","year":"2014","journal-title":"PLoS One"},{"issue":"9","key":"ref18","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1093\/cid\/civ556","article-title":"Long-term virological outcomes of first-line antiretroviral therapy for HIV-1 in low- and middle-income countries: A systematic review and meta-analysis","author":"TS Boender","year":"2015","journal-title":"Clin Infect Dis"},{"key":"ref19","unstructured":"WHO. Consolidated strategic information guidelines for HIV in the health sector. May 2015. http:\/\/www.who.int\/hiv\/pub\/guidelines\/strategic-information-guidelines\/en\/<\/ext-link>"},{"issue":"20","key":"ref20","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/01.aids.0000199825.34241.49","article-title":"Adherence-resistance relationships for protease and non-nucleoside reverse transcriptase inhibitors explained by virological fitness","author":"DR Bangsberg","year":"2006","journal-title":"AIDS"},{"issue":"37","key":"ref21","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1086\/378301","article-title":"Association between adherence to antiretroviral therapy and human immunodeficiency virus drug resistance","author":"AK Sethi","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"191","key":"ref22","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1086\/427192","article-title":"Predictors of HIV drug- resistance mutations in a large antiretroviral-naive cohort initiating triple antiretroviral therapy","author":"PR Harrigan","year":"2005","journal-title":"J Infect Dis"},{"issue":"146\u20138","key":"ref23","doi-asserted-by":"crossref","first-page":"564","DOI":"10.7326\/0003-4819-146-8-200704170-00007","article-title":"Adherence to non-nucleoside reverse transcriptase inhibitor-based HIV therapy and virologic outcomes","author":"JB Nachega","year":"2007","journal-title":"Ann Intern Med"},{"issue":"24","key":"ref24","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1089\/aid.2008.0141","article-title":"Relationship between adherence level, type of the antiretroviral regimen, and plasma HIV type 1 RNA viral load: a prospective cohort study","author":"M Martin","year":"2008","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"40","key":"ref25","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1086\/426595","article-title":"Similar adherence rates favor different virologic outcomes for patients treated with non- nucleoside analogues or protease inhibitors","author":"F Maggiolo","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"133","key":"ref26","doi-asserted-by":"crossref","first-page":"21","DOI":"10.7326\/0003-4819-133-1-200007040-00004","article-title":"Adherence to protease inhibitor therapy and outcomes in patients with HIV infection","author":"DL Paterson","year":"2000","journal-title":"Ann Intern Med"},{"issue":"50","key":"ref27","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/QAI.0b013e31819675e9","article-title":"The combined effect of modern highly active antiretroviral therapy regimens and adherence on mortality over time","author":"VD Lima","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"30","key":"ref28","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/00042560-200205010-00014","article-title":"Impact of adherence and highly active antiretroviral therapy on survival in HIV-infected patients","author":"P Garcia de Olalla","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"43","key":"ref29","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/01.qai.0000225015.43266.46","article-title":"Adherence to highly active antiretroviral therapy assessed by pharmacy claims predicts survival in HIV-infected South African adults","author":"JB Nachega","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"9","key":"ref30","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1086\/383572","article-title":"Predictors of Virologic Failure and Resistance in HIV-Infected Patients Treated with Nevirapine- or Efavirenz-Based Antiretroviral Therapy","volume":"38","author":"JJ Parienti","year":"2004","journal-title":"Clin Infect Dis"},{"key":"ref31","unstructured":"Ministry of Health and Child Care Zimbabwe HIV Drug Resistance Early Warning Indicators (EWI) Survey 2013 Report. 2013 October. Accessed on August 13, 2015."},{"issue":"6","key":"ref32","doi-asserted-by":"crossref","first-page":"e0129210","DOI":"10.1371\/journal.pone.0129210","article-title":"Monitoring HIV Drug Resistance Early Warning Indicators in Cameroon: A Study Following the Revised World Health Organization Recommendations","volume":"10","author":"J Fokam","year":"2015","journal-title":"PLoS ONE"},{"issue":"4","key":"ref33","doi-asserted-by":"crossref","first-page":"S280","DOI":"10.1093\/cid\/cis207","article-title":"HIV drug resistance early warning indicators in cohorts of individuals starting antiretroviral therapy between 2004 and 2009: World Health Organization global report from 50 countries","volume":"54","author":"DE Bennett","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"21","key":"ref34","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1097\/QAD.0b013e32802e6bfa","article-title":"Treatment interruptions predict resistance in HIV-positive individuals purchasing fixed-dose combination antiretroviral therapy in Kampala, Uganda","author":"JH Oyugi","year":"2007","journal-title":"AIDS"},{"issue":"6","key":"ref35","doi-asserted-by":"crossref","first-page":"e5790","DOI":"10.1371\/journal.pone.0005790","article-title":"Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis","volume":"4","author":"MW Brinkhof","year":"2009","journal-title":"PLoS One"},{"issue":"9","key":"ref36","doi-asserted-by":"crossref","first-page":"e75761","DOI":"10.1371\/journal.pone.0075761","article-title":"Are they really lost? \u201cTrue\u201d status and reasons for treatment discontinuation among HIV infected patients on antiretroviral therapy considered lost to follow up in urban Malawi","volume":"8","author":"H Tweya","year":"2013","journal-title":"PLoS ONE"},{"issue":"4","key":"ref37","doi-asserted-by":"crossref","first-page":"S294","DOI":"10.1093\/cid\/cir1015","article-title":"Early warning indicators for population-based monitoring of HIV drug resistance in 6 African countries","volume":"54","author":"KC Sigaloff","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"4","key":"ref38","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/QAI.0000000000000509","article-title":"Population-based surveillance of HIV drug resistance emerging on treatment and associated factors at sentinel antiretroviral therapy sites in Namibia","volume":"68","author":"SY Hong","year":"2015","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"ref39","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1365-3156.2010.02503.x","article-title":"Outcome assessment of decentralization of antiretroviral therapy provision in a rural district of Malawi using an integrated primary care model","volume":"15","author":"A Chan","year":"2010","journal-title":"Trop Med Int Health"},{"issue":"1","key":"ref40","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1097\/QAI.0000000000000264","article-title":"Decentralization of HIV care and treatment services in Central Province, Kenya","volume":"67","author":"WJ Reidy","year":"2014","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1186\/1471-2458-13-308","article-title":"Declining trends in early warning indicators for HIV drug resistance in Cameroon from 2008\u20132010: lessons and challenges for low-resource settings","volume":"13","author":"J Fokam","year":"2013","journal-title":"BMC Public Health"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0166649","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T02:35:25Z","timestamp":1588991725000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0166649"}},"subtitle":[],"editor":[{"given":"Dimitrios","family":"Paraskevis","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2016,12,1]]},"references-count":41,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2016,12,1]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0166649","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,1]]}}}